{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:05:44Z","timestamp":1777482344575,"version":"3.51.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-310"],"award-info":[{"award-number":["P3-310"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0043"],"award-info":[{"award-number":["P3-0043"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3 6790"],"award-info":[{"award-number":["J3 6790"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3 6789"],"award-info":[{"award-number":["J3 6789"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3 7605"],"award-info":[{"award-number":["J3 7605"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins"},{"name":"COST Action","award":["BM1002"],"award-info":[{"award-number":["BM1002"]}]},{"name":"EU COST Action","award":["CM1207 \u2013 GLISTEN"],"award-info":[{"award-number":["CM1207 \u2013 GLISTEN"]}]},{"name":"EU COST Action","award":["CM1207 - EuroCellNet"],"award-info":[{"award-number":["CM1207 - EuroCellNet"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12035-019-1481-x","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:02:40Z","timestamp":1548831760000},"page":"5971-5986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fingolimod Suppresses the Proinflammatory Status of Interferon-\u03b3-Activated Cultured Rat Astrocytes"],"prefix":"10.1007","volume":"56","author":[{"given":"Sa\u0161a","family":"Trkov Bobnar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matja\u017e","family":"Stenovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Mi\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergej","family":"Pirkmajer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-3875","authenticated-orcid":false,"given":"Robert","family":"Zorec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"12","key":"1481_CR1","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/glia.22575","volume":"61","author":"JI Alvarez","year":"2013","unstructured":"Alvarez JI, Katayama T, Prat A (2013) Glial influence on the blood brain barrier. Glia 61(12):1939\u20131958. https:\/\/doi.org\/10.1002\/glia.22575","journal-title":"Glia"},{"issue":"5","key":"1481_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","volume":"22","author":"A Araque","year":"1999","unstructured":"Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22(5):208\u2013215","journal-title":"Trends Neurosci"},{"issue":"48","key":"1481_CR3","doi-asserted-by":"publisher","first-page":"47408","DOI":"10.1074\/jbc.M307687200","volume":"278","author":"A Billich","year":"2003","unstructured":"Billich A, Bornancin F, D\u00e9vay P, Mechtcheriakova D, Urtz N, Baumruker T (2003) Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278(48):47408\u201347415. https:\/\/doi.org\/10.1074\/jbc.M307687200","journal-title":"J Biol Chem"},{"issue":"28","key":"1481_CR4","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1016\/S0021-9258(19)84774-9","volume":"264","author":"M Bouvier","year":"1989","unstructured":"Bouvier M, Collins S, O'Dowd BF, Campbell PT, de Blasi A, Kobilka BK, MacGregor C, Irons GP et al (1989) Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 264(28):16786\u201316792","journal-title":"J Biol Chem"},{"issue":"3","key":"1481_CR5","first-page":"575","volume":"137","author":"EA Boyle","year":"1990","unstructured":"Boyle EA, McGeer PL (1990) Cellular immune response in multiple sclerosis plaques. Am J Pathol 137(3):575\u2013584","journal-title":"Am J Pathol"},{"issue":"5","key":"1481_CR6","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.4049\/jimmunol.0802954","volume":"182","author":"R Brambilla","year":"2009","unstructured":"Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L et al (2009) Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 182(5):2628\u20132640. https:\/\/doi.org\/10.4049\/jimmunol.0802954","journal-title":"J Immunol"},{"issue":"5","key":"1481_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","volume":"158","author":"V Brinkmann","year":"2009","unstructured":"Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158(5):1173\u20131182. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00451.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1481_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neuint.2003.11.005","volume":"45","author":"AM Brown","year":"2004","unstructured":"Brown AM, Baltan Tekk\u00f6k S, Ransom BR (2004) Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 45(4):529\u2013536. https:\/\/doi.org\/10.1016\/j.neuint.2003.11.005","journal-title":"Neurochem Int"},{"issue":"1","key":"1481_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1096\/fj.08-109439","volume":"23","author":"A Bunbury","year":"2009","unstructured":"Bunbury A, Potolicchio I, Maitra R, Santambrogio L (2009) Functional analysis of monocyte MHC class II compartments. FASEB J 23(1):164\u2013171. https:\/\/doi.org\/10.1096\/fj.08-109439","journal-title":"FASEB J"},{"issue":"4","key":"1481_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797","journal-title":"Clin Chem"},{"issue":"2","key":"1481_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0165-5728(94)90075-2","volume":"51","author":"L B\u00f6","year":"1994","unstructured":"B\u00f6 L, M\u00f6rk S, Kong PA, Nyland H, Pardo CA, Trapp BD (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51(2):135\u2013146","journal-title":"J Neuroimmunol"},{"issue":"287","key":"1481_CR12","doi-asserted-by":"publisher","first-page":"287ra274","DOI":"10.1126\/scitranslmed.aaa8038","volume":"7","author":"Y Cao","year":"2015","unstructured":"Cao Y, Goods BA, Raddassi K, Nepom GT, Kwok WW, Love JC, Hafler DA (2015) Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis. Sci Transl Med 7(287):287ra274. https:\/\/doi.org\/10.1126\/scitranslmed.aaa8038","journal-title":"Sci Transl Med"},{"issue":"8","key":"1481_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(17)30113-8","volume":"16","author":"D Chan","year":"2017","unstructured":"Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R et al (2017) Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol 16(8):591\u2013600. https:\/\/doi.org\/10.1016\/S1474-4422(17)30113-8","journal-title":"Lancet Neurol"},{"issue":"9936","key":"1481_CR14","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","volume":"383","author":"J Chataway","year":"2014","unstructured":"Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR et al (2014) Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 383(9936):2213\u20132221. https:\/\/doi.org\/10.1016\/S0140-6736(13)62242-4","journal-title":"Lancet"},{"issue":"2","key":"1481_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.1014154108","volume":"108","author":"JW Choi","year":"2011","unstructured":"Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, Noguchi K, Teo ST, Yung YC et al (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A 108(2):751\u2013756. https:\/\/doi.org\/10.1073\/pnas.1014154108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6901","key":"1481_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nature01006","volume":"418","author":"A Chow","year":"2002","unstructured":"Chow A, Toomre D, Garrett W, Mellman I (2002) Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418(6901):988\u2013994. https:\/\/doi.org\/10.1038\/nature01006","journal-title":"Nature"},{"issue":"64","key":"1481_CR17","first-page":"213","volume":"12","author":"J Chun","year":"2011","unstructured":"Chun J, Brinkmann V (2011) A mechanistically novel, first oral therapy for multiple sclerosis: The development of fingolimod (FTY720, Gilenya). Discov Med 12(64):213\u2013228","journal-title":"Discov Med"},{"issue":"2","key":"1481_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP (2010) Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 33(2):91\u2013101. https:\/\/doi.org\/10.1097\/WNF.0b013e3181cbf825","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"1481_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.24217","volume":"76","author":"E Colombo","year":"2014","unstructured":"Colombo E, Di Dario M, Capitolo E, Chaabane L, Newcombe J, Martino G, Farina C (2014) Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide. Ann Neurol 76(3):325\u2013337. https:\/\/doi.org\/10.1002\/ana.24217","journal-title":"Ann Neurol"},{"issue":"4","key":"1481_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuint.2010.02.012","volume":"57","author":"J Keyser De","year":"2010","unstructured":"De Keyser J, Laureys G, Demol F, Wilczak N, Mostert J, Clinckers R (2010) Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. Neurochem Int 57(4):446\u2013450. https:\/\/doi.org\/10.1016\/j.neuint.2010.02.012","journal-title":"Neurochem Int"},{"issue":"1\u20132","key":"1481_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2007.08.044","volume":"267","author":"J Keyser De","year":"2008","unstructured":"De Keyser J, Mostert JP, Koch MW (2008) Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 267(1\u20132):3\u201316. https:\/\/doi.org\/10.1016\/j.jns.2007.08.044","journal-title":"J Neurol Sci"},{"issue":"8","key":"1481_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1212\/WNL.53.8.1628","volume":"53","author":"J Keyser De","year":"1999","unstructured":"De Keyser J, Wilczak N, Leta R, Streetland C (1999) Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53(8):1628\u20131633","journal-title":"Neurology"},{"issue":"1","key":"1481_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/archneur.60.1.132","volume":"60","author":"J Keyser De","year":"2003","unstructured":"De Keyser J, Zeinstra E, Frohman E (2003) Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch Neurol 60(1):132\u2013136","journal-title":"Arch Neurol"},{"issue":"2","key":"1481_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.nbd.2003.10.012","volume":"15","author":"J Keyser De","year":"2004","unstructured":"De Keyser J, Zeinstra E, Wilczak N (2004) Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol Dis 15(2):331\u2013339. https:\/\/doi.org\/10.1016\/j.nbd.2003.10.012","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1481_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12031-012-9742-4","volume":"48","author":"JH Dong","year":"2012","unstructured":"Dong JH, Chen X, Cui M, Yu X, Pang Q, Sun JP (2012) \u03b22-adrenergic receptor and astrocyte glucose metabolism. J Mol Neurosci 48(2):456\u2013463. https:\/\/doi.org\/10.1007\/s12031-012-9742-4","journal-title":"J Mol Neurosci"},{"issue":"3","key":"1481_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","volume":"28","author":"C Farina","year":"2007","unstructured":"Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28(3):138\u2013145. https:\/\/doi.org\/10.1016\/j.it.2007.01.005","journal-title":"Trends Immunol"},{"issue":"2","key":"1481_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.107.127183","volume":"323","author":"CA Foster","year":"2007","unstructured":"Foster CA, Howard LM, Schweitzer A, Persohn E, Hiestand PC, Balatoni B, Reuschel R, Beerli C et al (2007) Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther 323(2):469\u2013475. https:\/\/doi.org\/10.1124\/jpet.107.127183","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1481_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0165-5728(89)90030-1","volume":"23","author":"EM Frohman","year":"1989","unstructured":"Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S (1989) The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 23(2):117\u2013124","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1481_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1011016124524","volume":"21","author":"EM Frohman","year":"2001","unstructured":"Frohman EM, Monson NL, Lovett-Racke AE, Racke MK (2001) Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis. J Clin Immunol 21(2):61\u201373","journal-title":"J Clin Immunol"},{"issue":"4","key":"1481_CR30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1073\/pnas.85.4.1292","volume":"85","author":"EM Frohman","year":"1988","unstructured":"Frohman EM, Vayuvegula B, Gupta S, van den Noort S (1988) Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc Natl Acad Sci U S A 85(4):1292\u20131296","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1481_CR31","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI60746","volume":"122","author":"S Fukuhara","year":"2012","unstructured":"Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, Tokudome T, Sunden Y, Arai Y et al (2012) The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest 122(4):1416\u20131426. https:\/\/doi.org\/10.1172\/JCI60746","journal-title":"J Clin Invest"},{"issue":"6","key":"1481_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9(6):393\u2013407. https:\/\/doi.org\/10.1038\/nri2550","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"1481_CR33","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s11064-012-0773-6","volume":"37","author":"A Gu\u010dek","year":"2012","unstructured":"Gu\u010dek A, Vardjan N, Zorec R (2012) Exocytosis in astrocytes: transmitter release and membrane signal regulation. Neurochem Res 37(11):2351\u20132363. https:\/\/doi.org\/10.1007\/s11064-012-0773-6","journal-title":"Neurochem Res"},{"issue":"33","key":"1481_CR34","doi-asserted-by":"crossref","first-page":"19928","DOI":"10.1016\/S0021-9258(19)47200-1","volume":"264","author":"JR Hadcock","year":"1989","unstructured":"Hadcock JR, Wang HY, Malbon CC (1989) Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem 264(33):19928\u201319933","journal-title":"J Biol Chem"},{"issue":"1","key":"1481_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord 26(1):6\u201317. https:\/\/doi.org\/10.1002\/mds.23455","journal-title":"Mov Disord"},{"key":"1481_CR36","first-page":"27","volume":"17","author":"DR Harder","year":"2002","unstructured":"Harder DR, Zhang C, Gebremedhin D (2002) Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci 17:27\u201331","journal-title":"News Physiol Sci"},{"issue":"4","key":"1481_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/ana.410240408","volume":"24","author":"T Hayashi","year":"1988","unstructured":"Hayashi T, Morimoto C, Burks JS, Kerr C, Hauser SL (1988) Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens. Ann Neurol 24(4):523\u2013531. https:\/\/doi.org\/10.1002\/ana.410240408","journal-title":"Ann Neurol"},{"issue":"3","key":"1481_CR38","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1074\/jbc.M110.171116","volume":"286","author":"Y Hisano","year":"2011","unstructured":"Hisano Y, Kobayashi N, Kawahara A, Yamaguchi A, Nishi T (2011) The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem 286(3):1758\u20131766. https:\/\/doi.org\/10.1074\/jbc.M110.171116","journal-title":"J Biol Chem"},{"key":"1481_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","volume":"210","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210:171\u2013186. https:\/\/doi.org\/10.1111\/j.0105-2896.2006.00375.x","journal-title":"Immunol Rev"},{"issue":"4","key":"1481_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ceca.2016.01.002","volume":"59","author":"A Horvat","year":"2016","unstructured":"Horvat A, Zorec R, Vardjan N (2016) Adrenergic stimulation of single rat astrocytes results in distinct temporal changes in intracellular Ca(2+) and cAMP-dependent PKA responses. Cell Calcium 59(4):156\u2013163. https:\/\/doi.org\/10.1016\/j.ceca.2016.01.002","journal-title":"Cell Calcium"},{"issue":"2","key":"1481_CR41","first-page":"206","volume":"48","author":"K Hosoda","year":"1995","unstructured":"Hosoda K, Fitzgerald LR, Vaidya VA, Feussner GK, Fishman PH, Duman RS (1995) Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition. Mol Pharmacol 48(2):206\u2013211","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1481_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362(5):387\u2013401. https:\/\/doi.org\/10.1056\/NEJMoa0909494","journal-title":"N Engl J Med"},{"issue":"9","key":"1481_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/archneurol.2010.222","volume":"67","author":"SJ Khoury","year":"2010","unstructured":"Khoury SJ, Healy BC, Kivis\u00e4kk P, Viglietta V, Egorova S, Guttmann CR, Wedgwood JF, Hafler DA et al (2010) A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. Arch Neurol 67(9):1055\u20131061. https:\/\/doi.org\/10.1001\/archneurol.2010.222","journal-title":"Arch Neurol"},{"issue":"7","key":"1481_CR44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbalip.2009.02.011","volume":"1791","author":"RH Kim","year":"2009","unstructured":"Kim RH, Takabe K, Milstien S, Spiegel S (2009) Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta 1791(7):692\u2013696. https:\/\/doi.org\/10.1016\/j.bbalip.2009.02.011","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1481_CR45","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1194\/jlr.M500468-JLR200","volume":"47","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Nishi T, Hirata T, Kihara A, Sano T, Igarashi Y, Yamaguchi A (2006) Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J Lipid Res 47(3):614\u2013621. https:\/\/doi.org\/10.1194\/jlr.M500468-JLR200","journal-title":"J Lipid Res"},{"issue":"32","key":"1481_CR46","doi-asserted-by":"publisher","first-page":"21192","DOI":"10.1074\/jbc.M109.006163","volume":"284","author":"N Kobayashi","year":"2009","unstructured":"Kobayashi N, Yamaguchi A, Nishi T (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 284(32):21192\u201321200. https:\/\/doi.org\/10.1074\/jbc.M109.006163","journal-title":"J Biol Chem"},{"key":"1481_CR47","doi-asserted-by":"publisher","first-page":"CD009371","DOI":"10.1002\/14651858.CD009371.pub2","volume":"4","author":"L Mantia La","year":"2016","unstructured":"La Mantia L, Tramacere I, Firwana B, Pacchetti I, Palumbo R, Filippini G (2016) Fingolimod for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev 4:CD009371. https:\/\/doi.org\/10.1002\/14651858.CD009371.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1481_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005072-199003000-00005","volume":"49","author":"SC Lee","year":"1990","unstructured":"Lee SC, Moore GR, Golenwsky G, Raine CS (1990) Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 49(2):122\u2013136","journal-title":"J Neuropathol Exp Neurol"},{"key":"1481_CR49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","volume":"9","author":"SM Leibowitz","year":"2016","unstructured":"Leibowitz SM, Yan J (2016) NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci 9:84. https:\/\/doi.org\/10.3389\/fnmol.2016.00084","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1481_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720511794604543","volume":"8","author":"C Li","year":"2011","unstructured":"Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Yu AC (2011) Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8(1):67\u201380","journal-title":"Curr Alzheimer Res"},{"issue":"30","key":"1481_CR51","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1523\/JNEUROSCI.0744-08.2008","volume":"28","author":"D Li","year":"2008","unstructured":"Li D, Ropert N, Koulakoff A, Giaume C, Oheim M (2008) Lysosomes are the major vesicular compartment undergoing Ca2+-regulated exocytosis from cortical astrocytes. J Neurosci 28(30):7648\u20137658. https:\/\/doi.org\/10.1523\/JNEUROSCI.0744-08.2008","journal-title":"J Neurosci"},{"issue":"5","key":"1481_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/1756285611413825","volume":"4","author":"V Limmroth","year":"2011","unstructured":"Limmroth V, Putzki N, Kachuck NJ (2011) The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination. Ther Adv Neurol Disord 4(5):281\u2013296. https:\/\/doi.org\/10.1177\/1756285611413825","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1481_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-200216010-00001","volume":"16","author":"K Makhlouf","year":"2002","unstructured":"Makhlouf K, Weiner HL, Khoury SJ (2002) Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol). CNS Drugs 16(1):1\u20138","journal-title":"CNS Drugs"},{"issue":"2","key":"1481_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/tra.12026","volume":"14","author":"AR Mantegazza","year":"2013","unstructured":"Mantegazza AR, Magalhaes JG, Amigorena S, Marks MS (2013) Presentation of phagocytosed antigens by MHC class I and II. Traffic 14(2):135\u2013152. https:\/\/doi.org\/10.1111\/tra.12026","journal-title":"Traffic"},{"issue":"3","key":"1481_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107(3):247\u2013254. https:\/\/doi.org\/10.1172\/JCI11916","journal-title":"J Clin Invest"},{"issue":"9","key":"1481_CR56","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ni1507","volume":"8","author":"HF McFarland","year":"2007","unstructured":"McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8(9):913\u2013919. https:\/\/doi.org\/10.1038\/ni1507","journal-title":"Nat Immunol"},{"issue":"9","key":"1481_CR57","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1124\/dmd.105.009001","volume":"34","author":"GM Meno-Tetang","year":"2006","unstructured":"Meno-Tetang GM, Li H, Mis S, Pyszczynski N, Heining P, Lowe P, Jusko WJ (2006) Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab Dispos 34(9):1480\u20131487. https:\/\/doi.org\/10.1124\/dmd.105.009001","journal-title":"Drug Metab Dispos"},{"issue":"17","key":"1481_CR58","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","volume":"24","author":"A Miguez","year":"2015","unstructured":"Miguez A, Garc\u00eda-D\u00edaz Barriga G, Brito V, Straccia M, Giralt A, Gin\u00e9s S, Canals JM, Alberch J (2015) Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. Hum Mol Genet 24(17):4958\u20134970. https:\/\/doi.org\/10.1093\/hmg\/ddv218","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"1481_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2008.06.031","volume":"274","author":"VE Miron","year":"2008","unstructured":"Miron VE, Schubart A, Antel JP (2008) Central nervous system-directed effects of FTY720 (fingolimod). J Neurol Sci 274(1\u20132):13\u201317. https:\/\/doi.org\/10.1016\/j.jns.2008.06.031","journal-title":"J Neurol Sci"},{"issue":"2","key":"1481_CR60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.158.2.614","volume":"158","author":"KM Nikcevich","year":"1997","unstructured":"Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD (1997) IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 158(2):614\u2013621","journal-title":"J Immunol"},{"issue":"1\u20132","key":"1481_CR61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jim.2007.10.015","volume":"329","author":"M Noursadeghi","year":"2008","unstructured":"Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, Katz DR (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J Immunol Methods 329(1\u20132):194\u2013200. https:\/\/doi.org\/10.1016\/j.jim.2007.10.015","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"1481_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-5793(03)01168-2","volume":"554","author":"SW Paugh","year":"2003","unstructured":"Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 554(1\u20132):189\u2013193","journal-title":"FEBS Lett"},{"issue":"3","key":"1481_CR63","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1182\/blood-2006-03-011437","volume":"109","author":"SG Payne","year":"2007","unstructured":"Payne SG, Oskeritzian CA, Griffiths R, Subramanian P, Barbour SE, Chalfant CE, Milstien S, Spiegel S (2007) The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood 109(3):1077\u20131085. https:\/\/doi.org\/10.1182\/blood-2006-03-011437","journal-title":"Blood"},{"issue":"3","key":"1481_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"T Philips","year":"2011","unstructured":"Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10(3):253\u2013263. https:\/\/doi.org\/10.1016\/S1474-4422(11)70015-1","journal-title":"Lancet Neurol"},{"issue":"2","key":"1481_CR65","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.bbrc.2005.02.030","volume":"329","author":"M Potokar","year":"2005","unstructured":"Potokar M, Kreft M, Pangrsic T, Zorec R (2005) Vesicle mobility studied in cultured astrocytes. Biochem Biophys Res Commun 329(2):678\u2013683. https:\/\/doi.org\/10.1016\/j.bbrc.2005.02.030","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1481_CR66","first-page":"277","volume":"26","author":"M Potokar","year":"2011","unstructured":"Potokar M, Stenovec M, Kreft M, Gabrijel M, Zorec R (2011) Physiopathologic dynamics of vesicle traffic in astrocytes. Histol Histopathol 26(2):277\u2013284","journal-title":"Histol Histopathol"},{"issue":"12","key":"1481_CR67","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archneur.1991.00530240048017","volume":"48","author":"RM Ransohoff","year":"1991","unstructured":"Ransohoff RM, Estes ML (1991) Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch Neurol 48(12):1244\u20131246","journal-title":"Arch Neurol"},{"issue":"8","key":"1481_CR68","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1073\/pnas.1615413114","volume":"114","author":"V Rothhammer","year":"2017","unstructured":"Rothhammer V, Kenison JE, Tjon E, Takenaka MC, de Lima KA, Borucki DM, Chao CC, Wilz A et al (2017) Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 114(8):2012\u20132017. https:\/\/doi.org\/10.1073\/pnas.1615413114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1481_CR69","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37(6):e45. https:\/\/doi.org\/10.1093\/nar\/gkp045","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1481_CR70","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1471-4159.2007.04958.x","volume":"103","author":"K Sato","year":"2007","unstructured":"Sato K, Malchinkhuu E, Horiuchi Y, Mogi C, Tomura H, Tosaka M, Yoshimoto Y, Kuwabara A et al (2007) Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J Neurochem 103(6):2610\u20132619. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04958.x","journal-title":"J Neurochem"},{"issue":"2","key":"1481_CR71","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1212\/WNL.45.2.367","volume":"45","author":"J Satoh","year":"1995","unstructured":"Satoh J, Paty DW, Kim SU (1995) Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology 45(2):367\u2013373","journal-title":"Neurology"},{"issue":"1","key":"1481_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/glia.440050111","volume":"5","author":"JP Schwartz","year":"1992","unstructured":"Schwartz JP, Wilson DJ (1992) Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 5(1):75\u201380. https:\/\/doi.org\/10.1002\/glia.440050111","journal-title":"Glia"},{"issue":"11","key":"1481_CR73","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.4049\/jimmunol.180.11.7636","volume":"180","author":"S Sehrawat","year":"2008","unstructured":"Sehrawat S, Rouse BT (2008) Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. J Immunol 180(11):7636\u20137647","journal-title":"J Immunol"},{"issue":"11","key":"1481_CR74","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.4049\/jimmunol.161.11.5959","volume":"161","author":"JM Soos","year":"1998","unstructured":"Soos JM, Morrow J, Ashley TA, Szente BE, Bikoff EK, Zamvil SS (1998) Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J Immunol 161(11):5959\u20135966","journal-title":"J Immunol"},{"issue":"11","key":"1481_CR75","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1096\/fj.03-1397fje","volume":"18","author":"M Stenovec","year":"2004","unstructured":"Stenovec M, Kreft M, Poberaj I, Betz WJ, Zorec R (2004) Slow spontaneous secretion from single large dense-core vesicles monitored in neuroendocrine cells. FASEB J 18(11):1270\u20131272. https:\/\/doi.org\/10.1096\/fj.03-1397fje","journal-title":"FASEB J"},{"issue":"4","key":"1481_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1748-1716.2011.02337.x","volume":"203","author":"M Stenovec","year":"2011","unstructured":"Stenovec M, Milosevic M, Petrusic V, Potokar M, Stevic Z, Prebil M, Kreft M, Trkov S et al (2011) Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes. Acta Physiol (Oxford) 203(4):457\u2013471. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02337.x","journal-title":"Acta Physiol (Oxford)"},{"issue":"1","key":"1481_CR77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/apha.12314","volume":"212","author":"M Stenovec","year":"2014","unstructured":"Stenovec M, Trkov S, Kreft M, Zorec R (2014) Alterations of calcium homoeostasis in cultured rat astrocytes evoked by bioactive sphingolipids. Acta Physiol (Oxford) 212(1):49\u201361. https:\/\/doi.org\/10.1111\/apha.12314","journal-title":"Acta Physiol (Oxford)"},{"issue":"2","key":"1481_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/glia.22931","volume":"64","author":"M Stenovec","year":"2016","unstructured":"Stenovec M, Trkov S, Lasi\u010d E, Terzieva S, Kreft M, Rodr\u00edguez Arellano JJ, Parpura V, Verkhratsky A et al (2016) Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment. Glia 64(2):317\u2013329. https:\/\/doi.org\/10.1002\/glia.22931","journal-title":"Glia"},{"issue":"14","key":"1481_CR79","doi-asserted-by":"publisher","first-page":"10477","DOI":"10.1074\/jbc.M109.064162","volume":"285","author":"K Takabe","year":"2010","unstructured":"Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M, Harikumar KB, Hait NC et al (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285(14):10477\u201310486. https:\/\/doi.org\/10.1074\/jbc.M109.064162","journal-title":"J Biol Chem"},{"issue":"9","key":"1481_CR80","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.4049\/jimmunol.160.9.4271","volume":"160","author":"L Tan","year":"1998","unstructured":"Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD (1998) Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL\/J astrocytes. J Immunol 160(9):4271\u20134279","journal-title":"J Immunol"},{"issue":"21","key":"1481_CR81","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1074\/jbc.270.21.12787","volume":"270","author":"BG Tholanikunnel","year":"1995","unstructured":"Tholanikunnel BG, Granneman JG, Malbon CC (1995) The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J Biol Chem 270(21):12787\u201312793","journal-title":"J Biol Chem"},{"issue":"9","key":"1481_CR82","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nm1277","volume":"11","author":"GF Tian","year":"2005","unstructured":"Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N et al (2005) An astrocytic basis of epilepsy. Nat Med 11(9):973\u2013981. https:\/\/doi.org\/10.1038\/nm1277","journal-title":"Nat Med"},{"issue":"1","key":"1481_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(85)80043-6","volume":"8","author":"U Traugott","year":"1985","unstructured":"Traugott U, Scheinberg LC, Raine CS (1985) On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 8(1):1\u201314","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1481_CR84","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/glia.22361","volume":"60","author":"S Trkov","year":"2012","unstructured":"Trkov S, Stenovec M, Kreft M, Potokar M, Parpura V, Davletov B, Zorec R (2012) Fingolimod\u2014a sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes. Glia 60(9):1406\u20131416. https:\/\/doi.org\/10.1002\/glia.22361","journal-title":"Glia"},{"issue":"4","key":"1481_CR85","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymeth.2010.02.003","volume":"50","author":"JM Tuomi","year":"2010","unstructured":"Tuomi JM, Voorbraak F, Jones DL, Ruijter JM (2010) Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. Methods 50(4):313\u2013322. https:\/\/doi.org\/10.1016\/j.ymeth.2010.02.003","journal-title":"Methods"},{"issue":"3","key":"1481_CR86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R Doorn van","year":"2012","unstructured":"van Doorn R, Nijland PG, Dekker N, Witte ME, Lopes-Pinheiro MA, van het Hof B, Kooij G, Reijerkerk A et al (2012) Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol 124(3):397\u2013410. https:\/\/doi.org\/10.1007\/s00401-012-1014-4","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1481_CR87","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/glia.21021","volume":"58","author":"R Doorn Van","year":"2010","unstructured":"Van Doorn R, Van Horssen J, Verzijl D, Witte M, Ronken E, Van Het Hof B, Lakeman K, Dijkstra CD et al (2010) Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Glia 58(12):1465\u20131476. https:\/\/doi.org\/10.1002\/glia.21021","journal-title":"Glia"},{"issue":"9","key":"1481_CR88","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/ni1372","volume":"7","author":"G Loo van","year":"2006","unstructured":"van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinz MR et al (2006) Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat Immunol 7(9):954\u2013961. https:\/\/doi.org\/10.1038\/ni1372","journal-title":"Nat Immunol"},{"key":"1481_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-144","volume":"9","author":"N Vardjan","year":"2012","unstructured":"Vardjan N, Gabrijel M, Potokar M, Svajger U, Kreft M, Jeras M, de Pablo Y, Faiz M et al (2012) IFN-\u03b3-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J Neuroinflammation 9:144. https:\/\/doi.org\/10.1186\/1742-2094-9-144","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1481_CR90","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/glia.22626","volume":"62","author":"N Vardjan","year":"2014","unstructured":"Vardjan N, Kreft M, Zorec R (2014) Dynamics of \u03b2-adrenergic\/cAMP signaling and morphological changes in cultured astrocytes. Glia 62(4):566\u2013579. https:\/\/doi.org\/10.1002\/glia.22626","journal-title":"Glia"},{"issue":"5","key":"1481_CR91","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/glia.22920","volume":"64","author":"N Vardjan","year":"2016","unstructured":"Vardjan N, Parpura V, Zorec R (2016) Loose excitation-secretion coupling in astrocytes. Glia 64(5):655\u2013667. https:\/\/doi.org\/10.1002\/glia.22920","journal-title":"Glia"},{"issue":"7","key":"1481_CR92","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1083\/jcb.200611147","volume":"176","author":"F Vascotto","year":"2007","unstructured":"Vascotto F, Lankar D, Faure-Andr\u00e9 G, Vargas P, Diaz J, Le Roux D, Yuseff MI, Sibarita JB et al (2007) The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J Cell Biol 176(7):1007\u20131019. https:\/\/doi.org\/10.1083\/jcb.200611147","journal-title":"J Cell Biol"},{"issue":"3","key":"1481_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.15252\/embj.201592705","volume":"35","author":"A Verkhratsky","year":"2016","unstructured":"Verkhratsky A, Matteoli M, Parpura V, Mothet JP, Zorec R (2016) Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J 35(3):239\u2013257. https:\/\/doi.org\/10.15252\/embj.201592705","journal-title":"EMBO J"},{"issue":"1","key":"1481_CR94","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98(1):239\u2013389. https:\/\/doi.org\/10.1152\/physrev.00042.2016","journal-title":"Physiol Rev"},{"issue":"2","key":"1481_CR95","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-5728(94)00153-F","volume":"56","author":"K Wiegmann","year":"1995","unstructured":"Wiegmann K, Muthyala S, Kim DH, Arnason BG, Chelmicka-Schorr E (1995) Beta-adrenergic agonists suppress chronic\/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol 56(2):201\u2013206","journal-title":"J Neuroimmunol"},{"key":"1481_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-41","volume":"10","author":"C Wu","year":"2013","unstructured":"Wu C, Leong SY, Moore CS, Cui QL, Gris P, Bernier LP, Johnson TA, S\u00e9gu\u00e9la P et al (2013) Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. J Neuroinflammation 10:41. https:\/\/doi.org\/10.1186\/1742-2094-10-41","journal-title":"J Neuroinflammation"},{"issue":"16","key":"1481_CR97","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-3-16","volume":"3","author":"E Zeinstra","year":"2006","unstructured":"Zeinstra E, Wilczak N, Chesik D, Glazenburg L, Kroese FG, De Keyser J (2006) Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes. J Neuroinflammation 3(16):16. https:\/\/doi.org\/10.1186\/1742-2094-3-16","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1481_CR98","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0304-3940(00)01254-4","volume":"289","author":"E Zeinstra","year":"2000","unstructured":"Zeinstra E, Wilczak N, De Keyser J (2000) [3H] dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci Lett 289(1):75\u201377","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1481_CR99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0165-5728(02)00462-9","volume":"135","author":"E Zeinstra","year":"2003","unstructured":"Zeinstra E, Wilczak N, De Keyser J (2003) Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J Neuroimmunol 135(1\u20132):166\u2013171","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1481_CR100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00001756-200001170-00018","volume":"11","author":"E Zeinstra","year":"2000","unstructured":"Zeinstra E, Wilczak N, Streefland C, De Keyser J (2000) Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 11(1):89\u201391","journal-title":"Neuroreport"},{"issue":"2","key":"1481_CR101","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ymthe.2016.12.008","volume":"25","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li X, Ciric B, Ma CG, Gran B, Rostami A, Zhang GX (2017) Effect of fingolimod on neural stem cells: a novel mechanism and broadened application for neural repair. Mol Ther 25(2):401\u2013415. https:\/\/doi.org\/10.1016\/j.ymthe.2016.12.008","journal-title":"Mol Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1481-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1481-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1481-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T08:18:17Z","timestamp":1694593097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1481-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1481-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. Care of the experimental animals was in accordance with European and Slovenian legislation (Official Gazette of the RS 38\/13; UVHVVR, no. U34401-47\/2014\/7). This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}